Deletion of the scavenger receptor Scarb1 in osteoblast progenitors and myeloid cells does not affect bone mass
Michela PalmieriiD, Teenamol E. Joseph, Horacio Gómez-AcevedoiD, Ha‐Neui KimiD, Stavros C. ManolagasiD, Charles A. O’BrieniD, Elena AmbroginiiD
Abstract
The scavenger receptor class B member 1 (SCARB1), encoded by Scarb1, is a cell surface receptor for high density lipoproteins, low density lipoproteins (LDL), oxidized LDL (OxLDL), and phosphocholine-containing oxidized phospholipids (PC-OxPLs). Scarb1 is expressed in multiple cell types, including osteoblasts and macrophages. PC-OxPLs, present on OxLDL and apoptotic cells, adversely affect bone metabolism. Overexpression of E06 IgM - a natural antibody that recognizes PC-OxPLs- increases cancellous and cortical bone at 6 months of age in both sexes and protects against age- and high fat diet- induced bone loss, by increasing bone formation. We have reported that SCARB1 is the most abundant scavenger receptor for OxPLs in osteoblastic cells, and osteoblasts derived from Scarb1 knockout mice (Scarb1 KO) are protected from the pro-apoptotic and anti-differentiating effects of OxLDL. Skeletal analysis of Scarb1 KO mice produced contradictory results, with some studies reporting elevated bone mass and others reporting low bone mass. To clarify if Scarb1 mediates the negative effects of PC-OxPLs in bone, we deleted it in osteoblast lineage cells using Osx1-Cre transgenic mice. Bone mineral density (BMD) measurements and micro-CT analysis of cancellous and cortical bone at 6 months of age did not reveal any differences between Scarb1{Delta}OSX-l mice and their wild-type (WT), Osx1-Cre, or Scarb1fl/fl littermate controls. We then investigated whether PC-OxPLs could exert their anti-osteogenic effects via activation of SCARB1 in myeloid cells by deleting Scarb1 in LysM-Cre expressing cells. BMD measurements and micro-CT analysis at 6 months of age did not show any differences between Scarb1{Delta}LysM mice and their WT, LysM-Cre, or Scarb1fl/fl controls. Based on this evidence, we conclude that Based on this evidence, we conclude that the adverse skeletal effects of PC-OxPLs in adult mice are not mediated by Scarb1 expressed in osteoblast lineage cells or myeloid cells.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 0.30
- Field percentile
- top 47%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Bone marrow adipogenic lineage precursors (MALPs) promote osteoclastogenesis in bone remodeling and pathologic bone loss
- Sclerostin blockade inhibits bone resorption through PDGF receptor signaling in osteoblast lineage cells
C. Thouverey, P. Apostolides, … S. Ferrari·bioRxiv·Sep 11, 2023
- RANKL from Bone Marrow Adipocytes Regulates Osteoclast Formation and Bone Loss in Mice
- Csf1 from marrow adipogenic precursors is required for osteoclast formation and hematopoiesis in bone
- CXCL12 in late-stage osteoblasts and osteocytes is required for load induced bone formation in mice
P. Cabahug-Zuckerman, C. Liu, … A. B. Castillo·bioRxiv·Aug 25, 2022
- Osteomacs support osteoclast-mediated resorption and contribute to bone pathology in a postmenopausal osteoporosis mouse model
L. Batoon, S. M. Millard, … A. Pettit·bioRxiv·Feb 5, 2021